Founded in 2015, Serigen Mediproducts operates in Health Tech industry. Initially focusing on harnessing the unique properties of silk proteins, the company evolved its offerings to include a range of...
Funding stage:
Undisclosed
Last funding:
28/08/2024
Total funding:
$815.12K+
Revenue:
Investors
Employee count:
45
Last 90d
45
Last 90d
Web traffic:
2.2K
2.2K
Last 30d
Last 30d
Serigen Mediproducts: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders62
Latest Filing Date23 April 2026- Funding Events31
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Serigen Mediproducts
As of 24 April 2026, Serigen Mediproducts's equity is held by 61 shareholders, with the top three being Anuya Nisal, Premnath Venugopalan, and IAN Alpha Fund.
Anuya Nisal holds the largest stake in Serigen Mediproducts at 31.4% as of 24 April 2026.
As of 24 April 2026, founders collectively hold 48.1% equity in Serigen Mediproducts.
As of 24 April 2026, investors collectively hold 28.3% equity in Serigen Mediproducts.
Serigen Mediproducts's ESOP pool stands at 6.1% of total equity as of 24 April 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links